Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588 [PMID: 39099827 DOI: 10.4239/wjd.v15.i7.1562]
Corresponding Author of This Article
Shu-Qin Zheng, MSc, Associate Professor, Department of Endo-crinology, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 33 Beiling Street, Huanggu District, Shenyang 110032, Liaoning Province, China. qxjzsq@sina.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Clinical and Translational Research
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 5 Analysis of topological parameters of key targets
Name
Degree centrality
Betweenness centrality
Closeness centrality
Degree
AKT1
155
6135.22026848002
0.00258397932816537
46
EGFR
127
2630.66165751648
0.00239234449760765
44
TNF
155
6936.3437260436
0.00257069408740359
43
SRC
129
3308.84927642964
0.00240384615384615
43
JUN
117
1696.42973120389
0.00232018561484918
43
CASP3
116
2086.85812276904
0.00233644859813084
43
MAPK3
119
2232.21929446136
0.00233100233100233
43
HSP90AA1
124
3622.00791458381
0.00235849056603773
41
STAT3
123
1881.06728458254
0.00234192037470726
40
ESR1
102
1938.43441498511
0.00224215246636771
38
Table 6 Kyoto Encyclopedia of Genes and Genomes enrichment results
ID
Term
Enrichment
P value
Count
hsa04933
AGE-RAGE signaling pathway in diabetic complications
10.2107004
2.05E-22
31
hsa05417
Lipid and atherosclerosis
6.12795222
3.17E-20
40
hsa04151
PI3K-Akt signaling pathway
4.55917914
3.19E-19
49
hsa04066
HIF-1 signaling pathway
8.15889052
7.92E-17
27
hsa04510
Focal adhesion
5.67892124
1.28E-16
35
hsa04014
Ras signaling pathway
5.16396821
4.42E-16
37
hsa04012
ErbB signaling pathway
8.91256580
3.47E-15
23
hsa04664
Fc epsilon RI signaling pathway
10.1719501
4.44E-15
21
hsa04931
Insulin resistance
7.62447759
7.90E-15
25
hsa04068
FoxO signaling pathway
6.78869516
1.03E-14
27
hsa04010
MAPK signaling pathway
4.25354962
3.49E-14
39
hsa04062
Chemokine signaling pathway
5.31807312
7.06E-14
31
hsa04926
Relaxin signaling pathway
6.38328356
5.15E-13
25
hsa05418
Fluid shear stress and atherosclerosis
5.92405453
2.81E-12
25
hsa04668
TNF signaling pathway
6.64533415
2.32E-12
23
hsa04657
IL-17 signaling pathway
5.95682590
1.70E-08
17
hsa04922
Glucagon signaling pathway
4.30961126
1.88E-05
14
hsa04614
Renin-angiotensin system
10.0245305
4.72E-05
7
hsa04960
Aldosterone-regulated sodium reabsorption
7.12167420
1.01E-04
8
hsa04152
AMPK signaling pathway
4.89982957
1.15E-07
18
Citation: Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588